Carcinoma, Neuroendocrine

"Carcinoma, Neuroendocrine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of carcinomas which share a characteristic morphology, often being composed of clusters and trabecular sheets of round "blue cells", granular chromatin, and an attenuated rim of poorly demarcated cytoplasm. Neuroendocrine tumors include carcinoids, small ("oat") cell carcinomas, medullary carcinoma of the thyroid, Merkel cell tumor, cutaneous neuroendocrine carcinoma, pancreatic islet cell tumors, and pheochromocytoma. Neurosecretory granules are found within the tumor cells. (Segen, Dictionary of Modern Medicine, 1992)

Descriptor ID	D018278
MeSH Number(s)	C04.557.465.625.650.240 C04.557.470.200.025.370 C04.557.580.625.650.240
Concept/Terms	Carcinoma, Neuroendocrine Carcinoma, Neuroendocrine Carcinomas, Neuroendocrine Neuroendocrine Carcinoma Neuroendocrine Carcinomas

Below are MeSH descriptors whose meaning is more general than "Carcinoma, Neuroendocrine".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Neoplasms, Germ Cell and Embryonal [C04.557.465]
Neuroectodermal Tumors [C04.557.465.625]
Neuroendocrine Tumors [C04.557.465.625.650]
Carcinoma, Neuroendocrine [C04.557.465.625.650.240]
Neoplasms, Glandular and Epithelial [C04.557.470]
Carcinoma [C04.557.470.200]
Adenocarcinoma [C04.557.470.200.025]
Carcinoma, Neuroendocrine [C04.557.470.200.025.370]
Neoplasms, Nerve Tissue [C04.557.580]
Neuroectodermal Tumors [C04.557.580.625]
Neuroendocrine Tumors [C04.557.580.625.650]
Carcinoma, Neuroendocrine [C04.557.580.625.650.240]

Below are MeSH descriptors whose meaning is related to "Carcinoma, Neuroendocrine".

Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Neuroendocrine".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Carcinoma, Neuroendocrine" by people in this website by year, and whether "Carcinoma, Neuroendocrine" was a major or minor topic of these publications.

Bar chart showing 14 publications over 8 distinct years, with a maximum of 4 publications in 2012

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2004	1	0	1
2008	1	0	1
2010	1	1	2
2011	3	0	3
2012	4	0	4
2017	1	0	1
2018	1	0	1
2021	1	0	1

Below are the most recent publications written about "Carcinoma, Neuroendocrine" by people in Profiles.

Cimic A, Vranic S, Arguello D, Contreras E, Gatalica Z, Swensen J. Molecular Profiling Reveals Limited Targetable Biomarkers in Neuroendocrine Carcinoma of the Cervix. Appl Immunohistochem Mol Morphol. 2021 04 01; 29(4):299-304.

View in: PubMed
Balakrishna P, George S, Hatoum H, Mukherjee S. Serotonin Pathway in Cancer. Int J Mol Sci. 2021 Jan 28; 22(3).

View in: PubMed
Vuong HG, Ho ATN, Tran TTK, Capdevila J, Benekli M, Nakazawa T, Katoh R, Kondo T. Efficacy and toxicity of sorafenib in the treatment of advanced medullary thyroid carcinoma: A systematic review and meta-analysis. Head Neck. 2019 08; 41(8):2823-2829.

View in: PubMed
Vranic S, Palazzo J, Sanati S, Florento E, Contreras E, Xiu J, Swensen J, Gatalica Z. Potential Novel Therapy Targets in Neuroendocrine Carcinomas of the Breast. Clin Breast Cancer. 2019 04; 19(2):131-136.

View in: PubMed
Vuong HG, Odate T, Ngo HTT, Pham TQ, Tran TTK, Mochizuki K, Nakazawa T, Katoh R, Kondo T. Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis. Endocr Relat Cancer. 2018 06; 25(6):633-641.

View in: PubMed
Vanden Borre P, Schrock AB, Anderson PM, Morris JC, Heilmann AM, Holmes O, Wang K, Johnson A, Waguespack SG, Ou SI, Khan S, Fung KM, Stephens PJ, Erlich RL, Miller VA, Ross JS, Ali SM. Pediatric, Adolescent, and Young Adult Thyroid Carcinoma Harbors Frequent and Diverse Targetable Genomic Alterations, Including Kinase Fusions. Oncologist. 2017 03; 22(3):255-263.

View in: PubMed
Adhikari LJ, Sciallis AP, Reynolds J, Jenkins S, Smith C, Stan MN, Nassar A. Clinicopathologic predictors of thyroid bed recurrence of differentiated thyroid cancer using ultrasound-guided fine-needle aspiration biopsies. Thyroid. 2013 Aug; 23(8):982-8.

View in: PubMed
Singhi AD, Chu LC, Tatsas AD, Shi C, Ellison TA, Fishman EK, Kawamoto S, Schulick RD, Wolfgang CL, Hruban RH, Edil BH. Cystic pancreatic neuroendocrine tumors: a clinicopathologic study. Am J Surg Pathol. 2012 Nov; 36(11):1666-73.

View in: PubMed
de Wilde RF, Heaphy CM, Maitra A, Meeker AK, Edil BH, Wolfgang CL, Ellison TA, Schulick RD, Molenaar IQ, Valk GD, Vriens MR, Borel Rinkes IH, Offerhaus GJ, Hruban RH, Matsukuma KE. Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod Pathol. 2012 Jul; 25(7):1033-9.

View in: PubMed
Engles CD, Slobodov G, Buethe DD, Lightfoot S, Culkin DJ. Primary mixed neuroendocrine carcinoma of the bladder with large cell component: a case report and review of the literature. Int Urol Nephrol. 2012 Aug; 44(4):1021-5.

View in: PubMed

People

Explore

Similar Concepts

Top Journals